Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
|Vol / Avg.78.775K / 110.526K||Mkt Cap3.998M|
|Day Range0.500 - 0.550||52 Wk Range0.462 - 8.515|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-13||HC Wainwright & Co.||Yi Chen||Reiterates||BuyBuy||Maintains||-||3.50|
|2023-11-06||HC Wainwright & Co.||Yi Chen||Maintains||BuyBuy||Raises||2.00||3.50|
|2023-08-24||HC Wainwright & Co.||Yi Chen||Reiterates||BuyBuy||Maintains||-||2.00|
|2023-08-14||HC Wainwright & Co.||Yi Chen||Maintains||BuyBuy||Lowers||7.00||2.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 3.50 expecting KPRX to rise to within 12 months (a possible 573.08% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.52 last updated November 30, 2023 at 11:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 26, 2024.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.